About Hamatologische Sprechstunde
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
German High-Grade Non-Hodgkin's Lymphoma Study Group
1
Heidelberg University
1
Clinical Trials at Hamatologische Sprechstunde
During the past decade, Hamatologische Sprechstunde conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
2002-06-01
2017-03-31
Completed
1,551
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hamatologische Sprechstunde
According to Clinical.Site data, the most researched conditions in "Hamatologische Sprechstunde" are
"Leukemia" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Hamatologische Sprechstunde" in a lesser frequency.
Clinical Trials Intervention Types at Hamatologische Sprechstunde
Most popular intervention types in "Hamatologische Sprechstunde" are "Biological" (2 trials), "Drug" (2 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "allogeneic bone marrow transplantation" (1 trials), "autologous bone marrow transplantation" (1 trials), "cyclophosphamide" (1 trials), "cytarabine" (1 trials) and "doxorubicin hydrochloride" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hamatologische Sprechstunde
The vast majority of trials in "Hamatologische Sprechstunde" are
2 trials for "All" genders.
Clinical Trials Status at Hamatologische Sprechstunde
Currently, there are NaN active trials in "Hamatologische Sprechstunde".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Hamatologische Sprechstunde,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hamatologische Sprechstunde, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".